YMDAF yields 3.70% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 10
Combined, YMDAF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of YMDAF + JNJ for your $10,000?
Yamada Holdings Co., Ltd., together with its subsidiaries, operates in the consumer electronics retailing activities. Its Consumer Electronics segment operates a network of consumer electronics stores that sell home appliances, home interiors, and living and furniture products, as well as engages in the specialty retailing of private label apparel products. The company's Housing segment provides smart and custom-built homes, as well as engages in home building, rebuilding, and sale, and renovation activities. Its Finance segment develops a range of financial products in the new builds, renovations, payment services, insurance products, and life planning. The company's Environmental segment is involved in the product reuse and recycling, waste reduction and disposal, and recycled materials usage activities. Its Other segment engages in the trading businesses in travel industry, and delivery and installation of electrical appliances. The company was formerly known as Yamada Denki Co., Ltd. and changed its name to Yamada Holdings Co., Ltd. in October 2020. Yamada Holdings Co., Ltd. was founded in 1973 and is headquartered in Takasaki, Japan.
Full YMDAF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.